Irritable bowel syndrome (IBS) is a functional gut disorder that typically manifests in early adult years. IBS patients report that pain is the most distressing symptom with the greatest impact on quality of life. Pain-sensitivity genes and the gut microbiome may influence severity of symptoms as well as response to self-management (SM) interventions. Based on current understanding of the science of SM, pain neurophysiology, and the gut-brain axis, our team developed a pain SM intervention to be added to evidence-based self-management instruction to increase the individual's SM knowledge and skills (self-efficacy, self-regulation, and goal-setting).
.
Current approaches to improve self-management (SM) of IBS-related pain do not target individual, context-specific factors of pain.
Therefore, individuals with IBS-related pain often endure a long and frustrating course of learning how to manage pain on their own. The proposed pilot project was developed based on this common situation and will provide preliminary data about feasibility and outcomes of an intervention with personalized pain SM with nurse-led support for individuals with IBS-related pain.
| IBS pain
IBS-related pain is associated with sensitization of the central nervous system, peripheral nervous system, and/or mechanisms engaged within the bowel (Camilleri, Lasch, & Zhou, 2012) . While it is unclear how abnormal pain signaling along the pain processing pathway contributes to IBS pain burden, approximately half of all patients with IBS have visceral hypersensitivity and report distress as a result (Frissora & Koch, 2005; Kanazawa, Hongo, & Fukudo, 2011; Whitehead, Palsson, & Jones, 2002) . Pain susceptibility is influenced by genetic variation, and IBS-related pain also is influenced by the gut microbiome (Hughes et al., 2013; Kerckhoffs et al., 2009; Rajilic-Stojanovic et al., 2011; Simren et al., 2013) . The brain-gutmicrobiota axis has been recognized recently as an important mechanism in the regulation of health and the pain/stress response (Dinan & Cryan, 2012) . This bidirectional communication network enables top-down signaling from the brain to influence the motor, sensory, and secretory modalities of the GI tract, and conversely, bottom-up signaling from the gut to affect brain function, especially in the hypothalamus and amygdala, which are devoted to emotion and pain/stress (Cong, Xu, Romisher, et al., 2016) .
Self-management of IBS symptoms is the crux of therapy, and strategies to support the daily integration of health behaviors to reduce the negative impact of this condition are needed (Fukudo et al., 2015) . Several groups have developed and tested IBS-SM programs and have found that IBS knowledge increases after web-based, individual or group, and telephone interventions (AHRQ, 2014; Chang, Lembo, & Sultan, 2014; Trinkley & Nahata, 2014 ). Heitkemper's team reported that an 8-week nurse-led IBS-SM intervention signicantly improved symptoms at 3 and 6 months when compared to usual care (Jarrett et al., 2009 (Jarrett et al., , 2016 . In addition, they found that a polymorphism of the COMT gene moderated the effect of the intervention on symptom improvement (Han et al., 2017) .
Adolescents and young adults, who are most often affected by IBS, reported a high-level of satisfaction with self-guided SM resources including symptom self-monitoring, goal setting, problem-solving, and pain coping skills training (Stinson et al., 2014) . Pain neuroscience education has also been found to reduce fear of pain, pain catastrophizing, and pain intensity (Robins, Perron, Heathcote, & Simons, 2016) .
This pilot study was guided by the Individual and Family SelfManagement Theory (IFSMT), in which SM takes place in the context of risk and protective factors specific to the condition, physical and social environment, and individual and family (Ryan & Sawin, 2009 ).
Because it has already been shown that IBS-SM interventions are equal or superior to usual care (Cong, Perry, Bernier, Young, & Starkweather, 2017) , the intervention tested the previous model against the addition of nurse-led social support component designed to personalize the use of SM skills and facilitate activation of skills into SM behaviors. Adolescents and young adults will be randomized to receive either the IBS pain SM intervention alone (control) or the IBS pain SM intervention plus the nurse-led support for monitoring and problem-solving (experimental group).
The aims of this study are to evaluate: (1) feasibility and acceptability of the intervention; (2) preliminary effectiveness of the IBS-pain SM intervention plus nurse-led support on pain responses, IBS-pain SM behaviors, and related health outcomes. A secondary aim is to explore the influence of contextual risk factors of IBS, including peripheral and central pain sensitivity, single-nucleotide polymorphisms (SNPs) of candidate pain-sensitivity genes, and the gut microbiome, on pain and SM behaviors.
| METHODS

| Study design
A randomized controlled longitudinal design is being used. Both the experimental and control groups will receive 10 electronic video modules focused on knowledge and skills of IBS SM. The experimental group also will receive one-on-one consultation with a nurse for personalized self-monitoring and goal setting. All participants will be followed for 12 weeks after enrollment, and primary outcomes will be measured at baseline, 6, and 12 weeks (see Figure 1) . The study protocol has been approved by the University institutional review board and affiliated study settings.
| Randomization
After giving written consent, participants are randomized into either the control or experimental group using a stratified and blocked randomization scheme (Figure 1 ). In this scheme, gender is the stratification factor and the block size is four. Together, these components result in approximately equal ratios of male:female participants in the two study groups throughout the study period.
Given the relatively small sample sizes in this study, achieving a balance of gender in the groups reduces the possibility that this covariate could operate as a confounding factor.
| Blinding
All efforts are made to maintain blinding of study team members to the group assignment of individual participants. This is done by limiting the number of team members who perform the randomization (1-2 members). The study nurses are only contacting participants in the experimental group. All other team members remain blinded to group assignment, including laboratory personnel who are processing the biological samples. Dummy codes will be applied to the dataset so that it is not possible to determine the randomization scheme.
| Study setting
The study participants are being recruited from the general community as well as targeted advertising at two large public university campuses and two gastrointestinal (GI) clinics in the Northeastern US. Recruitment is taking place through advertisements placed in local newspapers and transportation vehicles, general flyers in the community, public places, major local university campuses and hospitals, and email invitation at major campuses, which instruct potential participants to call a research-designated phone line. The intervention and data collection are conducted in the biobehavioral laboratories on the two university campuses.
| Participants
| Inclusion criteria
Those included will be: (1) men and women 18-29 years of age;
(2) with a diagnosis of IBS by a healthcare provider with current FIGURE 1 Data collection flow chart. Experimental group, IBS pain SM intervention plus the nurse-led support; Control, IBS pain SM intervention alone; QST, quantitative sensory testing; IBS, irritable bowel syndrome; SM, self-management; RN, registered nurse report of pain (volunteers asked to bring provider-verification of IBS diagnosis based on Rome-III criteria to initial study appointment); (3) able to read and speak English; and (4) have daily access to a computer connected to the internet.
| Exclusion criteria
(1) Other chronic painful conditions including but not limited to fibromyalgia, chronic pelvic pain, or chronic interstitial cystitis; (2) infectious diseases (hepatitis, HIV, MRSA); (3) celiac disease or inflammatory bowel disease; (4) diabetes mellitus; (5) serious mental health conditions (e.g., bipolar disorder, schizophrenia, and mania); (6) women during pregnancy or within 3 months postpartum; (7) regular use of opioids, iron supplements, prebiotics/probiotics or antibiotics, or substance abuse; and (8) injury to non-dominant hand or presence of open skin lesions, disturbed sensation, carpal tunnel syndrome, or rash. The rationale for these exclusion criteria is to control for correlates of pain sensitivity, genetic and genomic attributes, and IBS-related health outcomes.
| Sample size
Eighty male and female young adults will be recruited to the study and randomized into the intervention or control group, with 40 subjects in each group. We estimated the sample size by reference to previous studies that evaluated effects of SM interventions for individuals with IBS (Cong, Perry, et al., 2017) .
The most common outcome variable shared by these studies is the IBS-Quality of Life scale (Dorn et al., 2015; Hahn, Kirchdoerfer, Fullerton, & Mayer, 1997; Jarrett et al., 2009; Stinson et al., 2014) .
Across studies, standardized effects on this variable are typically either "medium" (Cohen's d ≈ 0.5) or "very large" (d ≥ 1.0). As the current study focuses on feasibility, acceptability, and preliminary assessments of effectiveness, our sample size objective reflects an expected intervention effect of d = 0.75, Types I and II error probabilities of 0.05 and 0.2, respectively, and possible attrition up to 30%.
A power analysis to detect differences in the gut microbiome in response to the IBS SM intervention was not possible because no related previous study was found. A sample of 40 participants in each group will provide preliminary data to investigate the effects of the IBS-pain SM intervention on the gut microbiome, while accounting for potential attrition.
| Intervention
| Online education and training modules (both groups)
The research team has developed 10 online modules, which span pathophysiology and symptoms management of IBS (see Table 1 ). The modules include: IBS-related pain neurophysiology and the brain-gut axis mechanism, triggers of IBS-related pain, medication use, IBS pain management strategies, such as medication use, progressive muscle relaxation, guided imagery, mindfulness, belly breathing, and pain problem-solving, as well as managing daily activities. Each module is approximately 5-10 min in length and contains animated contents with interactive learning strategies. Language and concepts are presented at an 8th grade level.
The development of these modules utilized university e-learning principles as well as the online learning standards provided by Quality Matters (Available online at: https://www.qualitymatters.org). The content of these modules was assessed by several healthcare providers for accuracy and relevance, and the usability was tested prior to the start of the study. The modules are distributed through the university's Research Electronic Data Capture (REDCap) system (Harris et al., 2009) , which is a web-based, secure, research-driven platform that supports data capture, validated data entry and export, and audit trails for tracking data manipulation. Upon completion of the consent process and the baseline data collection, participants in both the experimental and control groups are provided with a unique link to the REDCap to access these electronic video modules and are instructed to complete one module each day for the next 2 weeks.
| One-on-one consultation with a registered nurse (experimental group)
Two research nurses with active registered nurse (RN) licenses provide one-on-one consultation to the participants in the experi- 
| Online symptom self-monitoring diary (experimental group)
To facilitate self-monitoring, participants in the experimental group are asked to fill out a daily log of IBS symptom ratings during the 12-week study period. The online diary is distributed and completed via the REDCap and covers self-monitoring of IBS-pain, diet, sleep, stress, and stool quality. The diary takes a few minutes to complete each day and is introduced to the participant after the first RN consultation.
| Monitoring of physical activity (experimental group)
The participants are asked to record pedometer readings in the online diary. Physical activity has been shown to decrease symptoms of IBS (Johannesson, Simren, Strid, Bajor, & Sadik, 2011) as well as pain sensitivity (Dishman et al., 2006) , although the precise level (frequency and intensity) remains unclear. At the end of the first visit, an electronic pedometer (Pro-Form-SP-100 Pedometer) is given to participants to measure steps taken, distance traveled, and calories burned.
| Measurements and data collection
After obtaining informed consent and randomization, initial data collection as well as follow-up visits are scheduled (Figure 1 ). Table 2 outlines the self-report measurements to be used at baseline, 6, and 12 weeks. All study measurements are collected and managed using the university REDCap system. The pathophysiology of pain, visceral pain sensitivity and the brain gut axis will be covered in this module using simple terms, definitions of medical terminology and basic principles of neurophysiology and the microbiome.
| Demographics and general questionnaires
Triggers of IBS Common triggers of IBS, particularly psychological stress and certain foods, will be reviewed. Strategies to decrease psychological stress, food logging, and dietary modifications will be discussed.
IBS symptom management strategies Basic principles of symptom management will be discussed such as what symptoms mean, monitoring symptoms, tracking symptoms, and knowing your body (self-scanning). Pharmacological and non-pharmacological strategies for symptom management as well as recommendations for healthy living will be reviewed (e.g., physical activity, diet, avoiding/decreasing exposures to toxins and substances).
Pharmacological therapies General categories of IBS medications will be explained, including the mechanisms of action, indications and contraindications. Over the counter and herbal remedies will be discussed so that participants are aware of how they are used and side-effects. (e.g., Use of certain probiotics and their long-term effects).
Pain problem solving This module will discuss strategies to use for decreasing the impact of pain on daily life. Food logging, physical activity, socialization, and strengthening coping skills will be discussed.
Progressive muscle relaxation Methods to use for progressive muscle relaxation will be discussed, specifically related to the abdominal region.
Step-by-step instructions and demonstration of progressive muscle relaxation will be included.
Belly breathing Methods of belly breathing will be shown.
Step-by-step instructions on how to use belly breathing for anxiety, stress reduction and pain will be highlighted.
Guided imagery
Methods of using guided imagery will be reviewed.
Step-by-step instructions and demonstration will be given.
Mindfulness
Concepts of mindfulness will be reviewed. Application of mindfulness to daily life will be discussed.
Integration into daily life How to instructions on applying all the various concepts into daily life will be discussed with instructions on how to set weekly goals. Examples include incorporating breathing exercises, dietary changes, and coping strategies into weekly goals.
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| 125 foods can influence IBS pain (Bohn, Storsrud, Tornblom, Bengtsson, & Simren, 2013) . The self-reported FFQ will be used to measure the type and quantity of food intake (Kristal, Feng, Coates, Oberman, & George, 1997) .
| Brief pain inventory (BPI)
The BPI measures two domains of pain, the severity of pain and the degree to which pain interferes with feeling and function, using 0-10 rating scales (Keller et al., 2004) . The BPI process variable measures pain at the time of data collection, and the distal outcome measures pain at each data point.
| Coping strategies questionnaire-revised (CSQ-R)
The CSQ-R (Robinson et al., 1997 ) is designed to assess six cognitive coping responses to pain. Subjects rate the frequency of using each coping strategy and its perceived control over their pain on a 7-point Likert-type scale, from "never do that" to "always do that" (Robinson et al., 1997) .
| IBS-quality of life (IBS-QOL) questionnaire
The IBS-QOL is designed to assess QOL specific to IBS populations (Hahn et al., 1997) . A 5-point Likert scale is used to measure responses.
All item scores are summed, and higher scores show better QOL.
| Use of recommended pharmacological therapies and healthcare utilization
Subjects are asked to document the use of pharmacological therapies and number of visits to healthcare providers for their IBS pain in the past 6 weeks. Number of visits is summed within categories: primary care providers (e.g., internist, family medicine practitioner), specialists (e.g., gastroenterologist), mental health visits (counselor, psychiatrist, or psychologist), and complementary alternative therapists (e.g., acupuncturist, massage therapist).
| Pain sensitivity
Quantitative sensory testing (QST) is used to measure pain sensitivity using standardized stimuli to test both nociceptive and non-nociceptive systems in the periphery and central nervous systems (Rolke et al., 2006; Verdugo & Ochoa, 1992) . A standardized protocol of administration based on previous studies , including examination room conditions and instructions provided for the patient, are strictly followed by all research team members. A total of seven tests are used to quantify 13 functional sensory pathways.
The QST protocol will be run on the subject's non-dominant forearm. A practice run on the dominant forearm is performed in order to verify the participant's understanding of the protocol. The medial TABLE 2 Instruments administered at baseline, 6-weeks, and 12-weeks of the study 
items
Use of recommended pharmacological therapies and healthcare utilization Use of pharmacological therapies and number of visits in the past 6 weeks to healthcare providers for their IBS pain.
Various side of the non-dominant forearm is utilized for testing purposes. QST is conducted in the following order: mechanical cutaneous pain, thermal pain, and pressure pain. The protocol is described in detail in a previous manuscript .
| Pain-susceptibility SNPs genotyping
Buccal cell samples are collected at the time of initial visit. Participants are instructed to rinse their mouth twice with water and then roll the sterile buccal brush firmly on the inside of the check. The buccal cell sample is stored at −80°C in the biobehavioral laboratary until processing. Genomic DNA will then be extracted from buccal brushes using standard kits and protocols (Qiagen, Germantown, MD, Gentra® Puregene® Buccal Cell Kit, #158845) and stored at −80°C for subsequent processing in batches. Specific SNPs of interest as painsusceptibility genes include oxytocin receptor gene (OXTR), glucocorticoid receptor gene (NR3C1), OPRM1, COMT, and CYP2D6 (Hall et al., 2012; Karling et al., 2011; Makker, Chilimuri, & Bella, 2015; Song et al., 2012) . Taqman SNP genotyping assays (VIC/FAM) are performed according to manufacturer protocol using an Applied
Biosystems
Step One Plus PCR machine and ABI allelic discrimination software (Thermo Fisher Scientific, Waltham, MA).
| Gut microbiome sequencing
Participants are instructed to collect stool samples using the OMNIgene. GUT (OMR-200) collection kit (DNA Genotek Inc., Ottawa, Canada) and send back the samples within 1 week after the initial visit and at 6-and 12-week follow-up visits. Samples are then frozen and maintained at −80°C at the Center's biobehavioral laboratary until processing. 16S rRNA gene sequencing analysis is conducted at the university-run Microbial Analysis, Resource, and Service facility.
Bacterial DNA is then isolated from stool samples by a protocol tested in preliminary experiments (Cong, Judge et al., 2017; Cong, Xu, Janton et al., 2016) . The V4 region of the 16S rRNA genes of the microbial community has been shown to work well for human fecal samples. Using 16S rRNA sequencing of time series from different individuals, one can compare changes in the composition and diversity of the microbiome over time and between subjects.
The physiology of the gut microbiome is determined using RNA- 
| Data analysis
Study data are analyzed using the SPSS, SAS, and R statistical packages, as appropriate. Self-report clinical data is exported from the REDCap database to the SPSS v.23 database for management and analysis. QST and SNPs data are also entered into SPSS for analysis. Gut microbial data are analyzed using the Mothur software and imported into R 3.3.1. The final statistical analysis, including hypothesis testing, will be conducted using the R 3.3.1 package and SAS version 9.4 (Cary, NC). The plans for data analysis are described according to each aim.
For Aim 1, to document the feasibility of the study design and its interventions in the population of young adults with IBS, the analysis will include a description of the number of individuals invited to participate, the proportion of those individuals who meet inclusion criteria, and the proportion who eventually provide informed consent. Among those who are randomized to the two study groups, the summaries of completion of video modules and activity logs will be tallied. In the experimental group, daily IBS symptom ratings and completion of follow-up consultations with the study nurse will be examined. A rate of 75% for the completion of all modules, activity logs, and IBS symptom ratings will be deemed as adequate to demonstrate feasibility of the study protocol (Jarrett et al., 2016) . Of the 27 individuals who have completed the study, 14 were enrolled into the experimental group. One participant was randomized to the experimental arm but declined and opted to continue in the control arm. Of the participants in the experimental group, only 8 completed all entries in the daily log, although 11 of 14 completed at least half of the entries.
| Challenges encountered
At this time, the most challenging aspect of our study implementation has been the high dropout rate, currently at 28%. This dropout rate is similar in both the treatment and the control groups, and the majority of these dropouts occurred prior to 6 weeks (the second study visit). Of note, 30% of these dropouts were participants recruited within 1 month prior to the academic winter break. We speculate that timing of mid-term and final exams may have affected study participation as well as subject burden.
In order to address this issue of study retention, the research team initiated multiple strategies. The participants were contacted up to three times via email with reminders about future appointments. These reminders are built into the daily workings of the research laboratory and did not increase experimental burden. Possibly the most significant strategy was the modification in the consent process to stress the time commitment required for study participation. This included a detailed explanation of the time needed to watch the videos and complete the daily log. The study module video schedule was changed so that participants could watch them back-to-back as their schedule allowed, instead of having to watch them on specific days. The policy on stool sample delivery was also changed to allow for individuals to mail in samples at their convenience and receive an e-gift card. Future statistical analyses will determine the effectiveness of the modifications on study retention.
Another issue that required attention was the slow recruitment rate within the first year of the study. To address this, the study team expanded clinical recruitment sites to two more campuses in the local region and increased the age limit to 29 years old. Also, noting the slow recruitment and high drop-out rate around exam and holiday weeks, the team made a conscious effort to monitor the scheduling accordingly.
Although challenges exist, it is hoped that this pilot study will demonstrate whether adding nurse consultations to existing instructional material can enhance symptom management in patients with IBS and whether pain-sensitivity genes and the gut microbiome can influence severity of symptoms as well as response to self-management (SM) interventions. The present study will inform larger tests of interventions to promote symptom management in this population. 
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